Code: 04514581

Mild Cognitive Impairment

Name: Mild Cognitive Impairment
Brand: Oxford University Press Inc
SKU: 04514581
Price: 118.79 EUR
Availability: BackOrder

by Mayo Clinic

Language: English
Binding: Hardback
Number of pages: 286
Publisher: Oxford University Press Inc, 2003
More about this

118.79 €

Print on demand
Shipping in 17 - 26 days

Add to wishlist

Rape Warfare
28.88 € -10 %
Buy
Houses by the Sea
28.28 € -4 %
Buy
Logic Programming and Nonmonotonic Reasoning
61.30 €
Buy
Destiny
15.59 €
Buy
Baroque Preludes For Violin, Viola Or Violoncello
21.64 € -2 %
Buy
Dennis Potter: Between Two Worlds
120.80 €
Buy
Corporate Social Responsibility
120.80 €
Buy
Molecular Variability of Fungal Pathogens
283.70 €
Buy
Immoral Bible
59.39 €
Buy
Finance and Development
77.01 €
Buy
Flood on the Tracks
36.74 € -19 %
Buy
Manual of Tropical Dermatology
61.30 €
Buy
Business English and Conversation
24.66 €
Buy
Illustrated History of Gospel
21.94 € -4 %
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

You get 299 loyalty points

Book synopsis

What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions about this condition and its underlying neuropathology remain open, full clinical trials are currently underway worldwide aimed at preventing the progression from MCI to Alzheimer's disease. This book addresses the spectrum of issues involved in mild cognitive impairment, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for clinicians, researchers, and students interested in aging and cognition, among them neurologists, psychiatrists, geriatricians, clinical psychologists, and neuropsychologists.